FDA Accepts MyMD Pharmaceuticals Investigational New Drug Application for Phase 2 Study of oral TNF- inhibitor MYMD-1 in Rheumatoid Arthritis
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
About 62% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
MYMD |
MyMD Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company committed to developing novel therapi
Read at businesswire.com
 |
MYMD Old Fundamental Analysis
We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
MYMD Old is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
MYMD Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.
Peers
MYMD Old Related Equities
| UBX | Unity Biotechnology | 34.59 | ||||
| NBY | NovaBay Pharmaceuticals | 9.37 | ||||
| PASG | Passage Bio | 1.52 | ||||
| GOVX | GeoVax Labs | 1.36 | ||||
| KZR | Kezar Life | 1.06 | ||||
| AVIR | Atea Pharmaceuticals | 2.10 | ||||
| KROS | Keros Therapeutics | 2.22 | ||||
| KRON | Kronos Bio | 3.03 | ||||
| LRMR | Larimar Therapeutics | 3.43 | ||||
| LGND | Ligand Pharmaceuticals | 3.89 | ||||
| REPL | Replimune | 4.08 | ||||
| RXRX | Recursion Pharmaceuticals | 5.23 | ||||
| BOLT | Bolt Biotherapeutics | 5.26 | ||||
| XBIO | Xenetic Biosciences | 5.39 | ||||
| NVCT | Nuvectis Pharma | 5.83 | ||||
| ORIC | Oric Pharmaceuticals | 6.35 | ||||
| GOSS | Gossamer Bio | 7.62 | ||||
| LYEL | Lyell Immunopharma | 7.69 | ||||
| REVB | Revelation Biosciences | 8.62 | ||||
| LYRA | Lyra Therapeutics | 9.09 | ||||
| DSGN | Design Therapeutics | 11.02 | ||||
| SRZN | Surrozen | 12.96 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in MYMD Stock
If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |